 Humberto Reyes-Pardo
Concepts (85)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sensory Receptor Cells | 2 | 2022 | 12 | 0.880 |
Why?
| | Diabetic Neuropathies | 1 | 2022 | 49 | 0.770 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2022 | 129 | 0.730 |
Why?
| | Membrane Transport Modulators | 1 | 2019 | 3 | 0.680 |
Why?
| | Sodium-Glucose Transporter 2 | 1 | 2019 | 18 | 0.670 |
Why?
| | Cell Membrane | 1 | 2019 | 249 | 0.620 |
Why?
| | Angiotensin II | 1 | 2019 | 162 | 0.610 |
Why?
| | Acute Kidney Injury | 1 | 2019 | 291 | 0.510 |
Why?
| | Nuclear Export Signals | 1 | 2012 | 2 | 0.410 |
Why?
| | RNA Polymerase II | 1 | 2012 | 12 | 0.410 |
Why?
| | Microalgae | 2 | 2022 | 4 | 0.410 |
Why?
| | Cell Nucleus | 1 | 2012 | 186 | 0.380 |
Why?
| | Bone Resorption | 2 | 2024 | 297 | 0.380 |
Why?
| | Mechanotransduction, Cellular | 2 | 2022 | 36 | 0.360 |
Why?
| | Disease Models, Animal | 2 | 2024 | 1411 | 0.280 |
Why?
| | Mice | 4 | 2024 | 5657 | 0.230 |
Why?
| | Rats | 2 | 2022 | 3273 | 0.230 |
Why?
| | Osteoclasts | 2 | 2024 | 424 | 0.230 |
Why?
| | Animals | 5 | 2024 | 13098 | 0.230 |
Why?
| | RANK Ligand | 1 | 2024 | 179 | 0.210 |
Why?
| | Deoxyribodipyrimidine Photo-Lyase | 1 | 2022 | 2 | 0.210 |
Why?
| | Osteomyelitis | 1 | 2024 | 125 | 0.210 |
Why?
| | Cosmetics | 1 | 2022 | 3 | 0.200 |
Why?
| | Refuse Disposal | 1 | 2022 | 4 | 0.200 |
Why?
| | Metals, Heavy | 1 | 2022 | 6 | 0.200 |
Why?
| | Water Pollutants | 1 | 2022 | 8 | 0.200 |
Why?
| | Ganglia, Spinal | 1 | 2022 | 52 | 0.200 |
Why?
| | Water Pollutants, Chemical | 1 | 2022 | 43 | 0.190 |
Why?
| | Staphylococcal Infections | 1 | 2024 | 269 | 0.190 |
Why?
| | Staphylococcus aureus | 1 | 2024 | 327 | 0.180 |
Why?
| | Osteocytes | 1 | 2023 | 214 | 0.180 |
Why?
| | Ruthenium Red | 1 | 2019 | 5 | 0.170 |
Why?
| | Elastic Modulus | 1 | 2019 | 12 | 0.170 |
Why?
| | Spider Venoms | 1 | 2019 | 6 | 0.170 |
Why?
| | Cadmium | 1 | 2019 | 21 | 0.170 |
Why?
| | Microvilli | 1 | 2019 | 6 | 0.170 |
Why?
| | Glucosides | 1 | 2019 | 13 | 0.170 |
Why?
| | Sodium-Glucose Transporter 1 | 1 | 2019 | 5 | 0.170 |
Why?
| | Losartan | 1 | 2019 | 27 | 0.170 |
Why?
| | Proteinuria | 1 | 2019 | 36 | 0.160 |
Why?
| | Pain | 1 | 2022 | 372 | 0.160 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2019 | 43 | 0.160 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2019 | 100 | 0.160 |
Why?
| | Glomerular Filtration Rate | 1 | 2019 | 110 | 0.160 |
Why?
| | Rats, Wistar | 1 | 2019 | 221 | 0.160 |
Why?
| | Benzhydryl Compounds | 1 | 2019 | 66 | 0.160 |
Why?
| | Rats, Sprague-Dawley | 1 | 2022 | 1578 | 0.150 |
Why?
| | Reactive Oxygen Species | 1 | 2019 | 405 | 0.140 |
Why?
| | Glucose | 1 | 2019 | 337 | 0.140 |
Why?
| | Cell Line | 1 | 2019 | 1010 | 0.140 |
Why?
| | Blood Pressure | 1 | 2019 | 520 | 0.140 |
Why?
| | RNA, Messenger | 1 | 2019 | 1099 | 0.130 |
Why?
| | Cells, Cultured | 1 | 2019 | 1587 | 0.130 |
Why?
| | Hypertension | 1 | 2019 | 532 | 0.110 |
Why?
| | Signal Transduction | 1 | 2019 | 1608 | 0.100 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2012 | 33 | 0.100 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 35 | 0.100 |
Why?
| | Conserved Sequence | 1 | 2012 | 56 | 0.100 |
Why?
| | Protein Structure, Secondary | 1 | 2012 | 71 | 0.100 |
Why?
| | Genes, Reporter | 1 | 2012 | 89 | 0.100 |
Why?
| | GTP-Binding Proteins | 1 | 2012 | 93 | 0.100 |
Why?
| | HEK293 Cells | 1 | 2012 | 216 | 0.100 |
Why?
| | Evolution, Molecular | 1 | 2012 | 97 | 0.100 |
Why?
| | Recombinant Fusion Proteins | 1 | 2012 | 186 | 0.100 |
Why?
| | Structure-Activity Relationship | 1 | 2012 | 394 | 0.090 |
Why?
| | Models, Molecular | 1 | 2012 | 334 | 0.090 |
Why?
| | Amino Acid Sequence | 1 | 2012 | 579 | 0.090 |
Why?
| | Molecular Sequence Data | 1 | 2012 | 799 | 0.090 |
Why?
| | Male | 2 | 2019 | 25427 | 0.080 |
Why?
| | Femur | 1 | 2024 | 130 | 0.060 |
Why?
| | Osteoprotegerin | 1 | 2023 | 52 | 0.050 |
Why?
| | Pyrimidine Dimers | 1 | 2022 | 2 | 0.050 |
Why?
| | Flavoproteins | 1 | 2022 | 5 | 0.050 |
Why?
| | Pyrimidinones | 1 | 2022 | 18 | 0.050 |
Why?
| | Ultraviolet Rays | 1 | 2022 | 49 | 0.050 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2024 | 223 | 0.050 |
Why?
| | Biodegradation, Environmental | 1 | 2022 | 8 | 0.050 |
Why?
| | Biotechnology | 1 | 2022 | 12 | 0.050 |
Why?
| | Soil | 1 | 2022 | 19 | 0.050 |
Why?
| | DNA Repair | 1 | 2022 | 185 | 0.050 |
Why?
| | Pyrimidines | 1 | 2022 | 192 | 0.050 |
Why?
| | Anti-Inflammatory Agents | 1 | 2022 | 160 | 0.050 |
Why?
| | Humans | 4 | 2024 | 49877 | 0.040 |
Why?
| | Antioxidants | 1 | 2022 | 234 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 742 | 0.030 |
Why?
|
|
Reyes-Pardo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|